Showing results (51-60 of 259) with videos related to

Sort By:
Pageof 26
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 13, 2005
Automated analysis of quetiapine and other antipsychotic drugs in human blood by high performance-liquid chromatography with column-switching and spectrophotometric detectionJulia Sachse, Johannes Köller, Sebastian Härtter, et al.
Therapeutic Drug Monitoring|November 29, 2007
Measurement of duloxetine in blood using high-performance liquid chromatography with spectrophotometric detection and column switchingChristine Waldschmitt, Friederike Vogel, Christian Maurer, et al.
Frontiers in Psychiatry|November 3, 2022
Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancyLuzie Eichentopf, Christoph Hiemke, Andreas Conca, et al.
Behavioural Brain Research|January 1, 2008
Pharmacodynamic consequences of P-glycoprotein-dependent pharmacokinetics of risperidone and haloperidol in miceKatrin M Kirschbaum, Stefanie Henken, Christoph Hiemke, et al.
Expert Review of Clinical Pharmacology|November 20, 2018
A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting paliperidoneGeorgios Schoretsanitis, Edoardo Spina, Christoph Hiemke, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 25, 2022
Pharmacokinetic drug interactions with oral haloperidol in adults: dose correction factors from a combined weighted analysisIan McGrane, Edoardo Spina, Christoph Hiemke, et al.
Psychiatrische Praxis|January 25, 2013
[Drug-drug-interactions in psychiatry]Martina Hahn, Julia Reiff, Christoph Hiemke, et al.
Expert Review of Clinical Pharmacology|May 20, 2018
A systematic review and combined analysis of therapeutic drug monitoring studies for oral paliperidoneGeorgios Schoretsanitis, Edoardo Spina, Christoph Hiemke, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 1, 2023
Personalized switching from oral to long-acting injectable second-generation antipsychotics in schizophrenia treatment using pharmacokinetic considerationsGeorgios Schoretsanitis, Jonathan M Meyer, Andreas Conca, et al.
Addiction (Abingdon, England)|May 28, 2009
A randomized trial of short psychotherapy versus sustained-release bupropion for smoking cessationGerald Zernig, Reinhild Wallner, Ursula Grohs, et al.
Pageof 26